Q3 2025 Gene, Cell, + RNA Therapy Landscape Report

As this ASGCT-Citeline report shows, clinical development slowed across gene, cell, and RNA therapies, with 125 trials initiated. However, the global pipeline remains robust, with more than 3,200 trials underway worldwide.

Download now to learn more.

PDF preview of the Q3 2025 Gene, Cell + RNA Therapy Landscape Report, available for download

First Name *

Last Name *

Company *

Job Title *

Business Email Address *

Country *

Business Phone

How Can We Help

fieldlabel

Citeline may contact you about relevant products, services, and content. To opt out of these communications or to manage what you receive, please visit our Preference Center.

Your information will be used in accordance with our Privacy notice.

Related products

Pharmaprojects

世界的な医薬品研究開発の状況を追跡し、分析するための業界標準

Supporting across your entire product lifecycle

Real World Data Solutions

3億人の米国市民に関する多様でトークン化されたリアルワールドのデータセットを活用して、臨床試験の計画と実施を患者中心の視点で行ってください。

Investigator SmartSelect

臨床試験に最適な治験責任医師を、迅速かつ的確にリストアップできます。

Related resources

Cloud storage icon with connected data nodes.

AUG 27, 2025

Article

Clinical

リアルワールドデータが切り拓く、臨床試験の新たな可能性

実世界データは、臨床試験の戦略立案、計画策定、実施支援に加え、ポートフォリオおよびパイプライン管理にも活用できる。

Image of an opened laptop showcasing the header "Citeline Real-World Data: Site/PI Selection and Patient Engagement" along with a sub-header, on screen

Use Case

Clinical

Site PI Selection and Pt Engagement

Learn how Citeline’s Real-World Data (RWD) can help you identify which investigators and physicians are treating protocol-matched patients to inform site selection and patient engagement.
Download Use Case

OCT 30, 2024

Article

薬事規制関連支援サービス

Artificial Intelligence Regulation

Drug sponsors strive to make the best use of artificial intelligence, but doing so requires understanding where health authorities are drawing the lines. Download a sample of our coverage from the US, Europe, and Asia of the emerging framework for AI regulation.

View all